2021-08-25 13:53 After your projects move to CDC optimization, let our therapeutic antibody development experts show you how to accelerate the development and unleash your CDC-enhanced antibody to an even greater potential. By the help of our specialists and their ex ... дальше
2021-08-25 13:53 Fc-mediated mechanisms complement-dependent cytotoxicity (CDC) is an important pathway to research for successful therapeutic intervention. Powered by our professional scientists and their years of field experience, Creative Biolabs is able to perfor ... дальше
2021-05-19 09:18 ADCC-Enhanced anti-Citrullinated Peptide is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform. By reducing the fucosylation of the Fc region, the ADCC-enhanced antibody shows an increased bind ... дальше
2021-05-19 09:18 ADCC-Enhanced anti-Citrullinated Peptide is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform. By reducing the fucosylation of the Fc region, the ADCC-enhanced antibody shows an increased bind ... дальше
2021-05-19 09:18 ADCC-Enhanced anti-Citrullinated Peptide is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform. By reducing the fucosylation of the Fc region, the ADCC-enhanced antibody shows an increased bind ... дальше
2021-05-19 09:18 ADCC-Enhanced anti-Citrullinated Peptide is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform. By reducing the fucosylation of the Fc region, the ADCC-enhanced antibody shows an increased bind ... дальше
2021-05-19 09:17 ADCC-Enhanced anti-Citrullinated Peptide is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform. By reducing the fucosylation of the Fc region, the ADCC-enhanced antibody shows an increased bind ... дальше
2021-05-19 09:17 ADCC-Enhanced anti-Citrullinated Peptide is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform. By reducing the fucosylation of the Fc region, the ADCC-enhanced antibody shows an increased bind ... дальше
2021-05-19 09:17 ADCC-Enhanced anti-Citrullinated Peptide is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform. By reducing the fucosylation of the Fc region, the ADCC-enhanced antibody shows an increased bind ... дальше
